Is N,1,5-Trimethyl-4-hexenylamine Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use N,1,5-Trimethyl-4-hexenylamine? Is N,1,5-Trimethyl-4-hexenylamine safe for nursing mother and child? Does N,1,5-Trimethyl-4-hexenylamine extracts into breast milk? Does N,1,5-Trimethyl-4-hexenylamine has any long term or short term side effects on infants? Can N,1,5-Trimethyl-4-hexenylamine influence milk supply or can N,1,5-Trimethyl-4-hexenylamine decrease milk supply in lactating mothers?

• DrLact safety Score for N,1,5-Trimethyl-4-hexenylamine is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of N,1,5-Trimethyl-4-hexenylamine may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that N,1,5-Trimethyl-4-hexenylamine may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using N,1,5-Trimethyl-4-hexenylamine .
• It is recommended to evaluate the advantage of not breastfeeding while using N,1,5-Trimethyl-4-hexenylamine Vs not using N,1,5-Trimethyl-4-hexenylamine And continue breastfeeding.
• While using N,1,5-Trimethyl-4-hexenylamine Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Seemingly a sympathomimetic drug with poor effect on Migraine relief. On latest update relevant data on breastfeeding was not found. Because a low excretion into breast milk Sumatriptan is a preferred drug. Other medication for Migraine relief like Triptans, Ibuprofen, Diclofenac and Ketorolate are more effective and at a lower risk for breastfeeding than N,1,5-Trimethyl-4-hexenylamine.